The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

FTSE 100 movers: BP boosted by lower-than-expected fine, ARM hit by Intel competition

Fri, 16th Jan 2015 12:53

Oil giant BP was among the risers after the company revealed it faces a maximum penalty of $13.7bn under the Clean Water Act. This follows the District Court for the Eastern District of Louisiana ruling on the Deepwater Horizon case, which found that 3.19m barrels of oil were discharged in the Gulf of Mexico in 2010. The bill, which was some $4bn less than feared, put the spill's size below the government's 4.09m estimate and just under the 3.26m estimated by the firm. Sector peer BHP Billiton was also up, after oil prices advanced on Friday morning. Brent futures were up 2.6% at $49.50 a barrel after the International Energy Agency (IEA) said a turnaround could be on the horizon. "A price recovery - barring any major disruption - may not be imminent, but signs are mounting that the tide will turn. A rebalancing may begin to occur in the second half of the year," the IEA said, as it lowered its forecasts for non-OPEC supply.Imperial Tobacco's share prices were boosted as Morgan Stanley hiked its target price from 2,680p to 3,250p and named the stock its new top pick, saying it is "increasingly optimistic" about its pending $7bn acquisition of assets from Reynolds and Lorillard.BT Group shares were also higher after being upgraded from 'hold' to 'buy' by Societe Generale.Meanwhile ARM Holdings took a hit after US chip rival Intel revealed it had sold more-than-expected chips for tablets in 2014 on Thursday night. Liberum kept a 'sell' rating on ARM, saying that competition from Intel is now rising in the smartphone sector, "which could take share from ARM in its core market".AstraZeneca was falling following a downgrade from Barclays Capital from 'equal weight' to 'underweight'. The broker said: "In an interview with The Times late last year CEO Pascal Soriot urged investors to not fixate on the Long-Range Plan central to its bid defence against Pfizer and to focus instead on margins. We view this as a tacit admission that management's $45 bn 2023 revenue projection is unrealistic and we view 2017 revenue guidance as equally unlikely to be met." RisersExperian (EXPN) 1,162.00p +3.66%Antofagasta (ANTO) 688.50p +2.76%BP (BP.) 403.40p +2.75%Glencore (GLEN) 247.05p +2.68%Anglo American (AAL) 1,087.00p +2.60%BG Group (BG.) 836.90p +2.01%BT Group (BT.A) 407.80p +1.90%BHP Billiton (BLT) 1,373.50p +1.89%Imperial Tobacco Group (IMT) 2,904.00p +1.89%Standard Life (SL.) 392.20p +1.24% FallerseasyJet (EZJ) 1,600.00p -2.74%Wolseley (WOS) 3,601.00p -2.54%Mondi (MNDI) 1,052.00p -2.41%Dixons Carphone (DC.) 424.30p -2.33%ARM Holdings (ARM) 974.00p -2.16%Babcock International Group (BAB) 1,003.00p -1.57%AstraZeneca (AZN) 4,661.50p -1.43%Burberry Group (BRBY) 1,661.00p -1.37%Persimmon (PSN) 1,436.00p -1.37%Meggitt (MGGT) 511.00p -1.35%

Related Shares

More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.